We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Linking Retinal Microvasculature to Silent Coronary Atherosclerosis: Insights from Optical Coherence Tomography Angiography

MedXY Editorial Team•Oct 9, 2025•Cardiology
Coronary Atherosclerosis

Highlight

This study from Asan Medical Center provides compelling evidence that decreased retinal parafoveal vascular density (PFVD), as assessed by optical coherence tomography angiography (OCTA), strongly associates with subclinical coronary artery disease (CAD) in asymptomatic individuals. The superficial capillary plexus (SCP) density offers superior predictive performance for coronary atherosclerotic burden compared to the deep capillary plexus (DCP). Incorporating PFVD metrics alongside traditional cardiovascular risk factors improves identification of obstructive and severe CAD, offering a promising adjunctive biomarker for early detection and risk stratification.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

GnRH Antagonists May Spare the Heart: Evidence of Reduced Coronary Plaque Progression in Prostate Cancer PatientsA randomized clinical trial indicates that the GnRH agonist leuprolide significantly accelerates coronary plaque progression compared to the antagonist relugolix in men with prostate cancer, suggesting a potential biological mechanism for dMar 9, 2026GnRH Agonists Linked to Accelerated Coronary Plaque Progression Compared to Antagonists in Prostate Cancer PatientsA randomized clinical trial demonstrates that the GnRH agonist leuprolide leads to significantly greater coronary plaque progression, specifically noncalcified plaque, compared to the antagonist relugolix in men with prostate cancer, offeriFeb 19, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story